October 2, 20250 citationsOpen Access
Supplementary Figure S5 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy
View Full Paper
Key Points
- A scar-like transcriptomic profile associates with favorable prognosis in bladder cancer post-therapy.
- This analysis displays downregulated genes in consensus stroma-rich tumors, revealing key genetic insights.
- The research involves differential gene expression analysis comparing specific tumor types to assess outcomes.
- These findings may highlight important implications for targeted treatment strategies in bladder cancer cases.
Abstract
Figure S5. Differential gene expression analysis comparing the CC-scar-like to the remaining Consensus stroma-rich tumors. Select downregulated genes have been circled in blue.